CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed
Drug / intervention
diet, reducingbehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00000615
NCT00000615Phase 2Completed
CompareCT.gov

Girls Health Enrichment Multi-Site Studies (GEMS)

Stanford University·interventional·Posted Oct 28, 1999·Updated May 6, 2021

In Brief

A Phase 2 clinical trial evaluating diet, reducing for Cardiovascular Diseases and 2 related conditions. Completed.

Detailed Summary

To develop and test interventions to prevent obesity by decreasing weight gain during the high-risk transitional period from pre-puberty to puberty in African-American girls who are at high risk for developing obesity.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCardiovascular Diseases, Heart Diseases, Obesity
Countries--
CollaboratorsNational Heart, Lung, and Blood Institute (NHLBI)

Timeline

Phase 2CompletedFinished
19992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedOct 28, 1999
Enrollment StartAug 1, 1999
Study CompletionNov 1, 2006
TodayJul 2, 2026
Posted 26.7 years ago

Interventions

diet, reducingbehavioral